President Donald Trump on Monday evening announced a fresh round of tariffs targeting timber, lumber, and furniture imports, marking the latest development in his administration’s trade policy actions.
According to a White House statement, the new measures will include a 10% tariff on softwood timber and lumber and a 25% tariff on certain upholstered wooden products. These tariffs are scheduled to take effect on October 14. The announcement follows a recent decision to apply new duties on kitchen cabinets, vanities, and other furniture items beginning October 1.
The administration emphasized that the tariffs are intended to reinforce supply chain stability and strengthen domestic manufacturing resilience. However, industry groups, particularly home builders, have expressed concern that the added costs could discourage investments in housing development and renovation projects. Canada, the United States’ largest supplier of wood, is expected to be significantly affected by the new measures. Canadian exports of timber and lumber are already subject to duties exceeding 35%, and the latest announcement is likely to intensify trade pressures between the two countries.
Earlier in the day, President Trump had also announced 100% tariffs on foreign films and indicated that “substantial” new duties would be placed on additional categories of imported furniture. These moves are part of what analysts describe as a renewed “tariff blitz” aimed at multiple industries in a short time frame.
In addition to consumer goods and furniture, the new tariff wave also extends to the pharmaceutical sector. A proposed 100% duty on patented drugs is set to apply unless drugmakers establish manufacturing plants in the United States or operate under a trade deal that covers pharmaceutical products.
Pfizer Inc. (PFE), however, announced on Tuesday that it has secured a three-year reprieve from the tariffs after reaching an agreement with the administration. The deal reportedly involves Pfizer offering some of its drugs at a discounted rate in exchange for the exemption, fueling speculation that other pharmaceutical companies may pursue similar arrangements.
On the international front, the United States and China reported progress toward a broader trade framework following a phone call between President Trump and Chinese President Xi Jinping. According to Trump, both countries reached an agreement to move forward with a plan for a U.S. spin-off of the TikTok app. The two leaders are expected to engage in a series of meetings in the coming months to continue negotiations.
Overall, the series of tariff announcements reflects the administration’s broader strategy of pressuring industries and trading partners while simultaneously seeking targeted agreements. Market observers are watching closely to assess how these policies may affect housing markets, retail prices, pharmaceutical availability, and global trade flows in the months ahead.
#TradePolicy #TariffUpdate #GlobalMarkets #SupplyChainNews #NewsUpdate
